Streetbeat News

Stock Prices

SPIR

Spire Global, Inc. (NYSE:SPIR) reported mixed Q1 results, with an adjusted loss per share better than expected but revenue missing estimates. The company lowered its FY24 revenue and EPS outlook, leading to a 6.8% drop in share price. Analysts from Baird and Stifel cut their price targets but maintained positive ratings.

Portfolio Pulse from Avi Kapoor

May 16, 2024 | 12:34 pm

LMFA

LM Funding America (NASDAQ:LMFA) reported Q1 2024 adjusted EPS of $0.61, significantly beating the analyst estimate of $(0.57). The company also reported sales of $4.75 million, surpassing the $4.70 million estimate and marking a 105.14% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:34 pm

BRK

CB

Warren Buffett's Berkshire Hathaway has acquired nearly 26 million shares of Chubb Ltd, making it Berkshire's ninth-largest holding. This move comes amid significant challenges in the insurance industry due to climate change. Despite these challenges, Buffett's investment indicates confidence in Chubb's long-term prospects.

Portfolio Pulse from Surbhi Jain

May 16, 2024 | 12:33 pm

MSAI

Infrared Cameras Holdings (NASDAQ:MSAI) reported a Q1 2024 GAAP EPS of $(0.33), significantly missing the $(0.05) estimate. Sales were $2.275M, slightly below the $2.300M estimate but up 132.14% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:33 pm

GH

Guardant Health, Inc. (NASDAQ:GH) will present data from two real-world studies at the 2024 Digestive Disease Week (DDW) meeting, showcasing the effectiveness of its Shield™ blood test for colorectal cancer (CRC) screening.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:32 pm

ATXI

Avenue Therapeutics has completed the last patient visit in its Phase 1b/2a clinical trial of AJ201 for Spinal and Bulbar Muscular Atrophy.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:32 pm

GCTK

Glucotrack announced that its implantable glucose monitor has successfully completed 30 days of a 60-day preclinical study.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:32 pm

SPY

Building permits for April came in at 1.44 million, falling short of the expected 1.48 million. This indicates a potential slowdown in the housing market.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:30 pm

SPY

Housing starts for April came in at 1.36 million, below the estimated 1.42 million. This shortfall may impact market sentiment, particularly in sectors related to housing and construction.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:30 pm

SPY

Building permits for April decreased by 3%, indicating a potential slowdown in the construction sector.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:30 pm